Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

NCT ID: NCT04273945

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

935 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-30

Study Completion Date

2029-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Arterial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Macitentan 10 milligrams (mg) + Placebo

Run-in period:Participants who are either endothelin receptor antagonist (ERA)-naïve or who are receiving daily dose of macitentan or ambrisentan less (\<) 10 milligrams (mg), or daily dose of bosentan \<250 mg, will enter 4-week open-label run-in period with macitentan 10 mg prior to randomization. ERA-pre-treated participants will bypass run-in period and will be randomized to either macitentan 75 mg or macitentan 10 mg directly.Double-blind Treatment (DBT) Period:Participants will receive macitentan 10 mg orally up to End of DBT.To maintain blind, participants will receive macitentan 37.5 mg-matching placebo for 4 weeks and macitentan 75 mg-matching placebo thereafter up to DBT.Treatment Extension Period:After EDBT, participants will receive macitentan 37.5 mg once a day (qd) orally for 4 weeks, prior to receiving open-label macitentan 75 mg qd orally for 2 years. To maintain blind, participants will receive macitentan 75 mg-matching placebo during 4-week uptitration.

Group Type ACTIVE_COMPARATOR

Macitentan 10 mg

Intervention Type DRUG

Participants will receive macitentan 10 mg film-coated tablets orally.

Macitentan 37.5 mg

Intervention Type DRUG

Participants will receive macitentan 37.5 mg film-coated tablets orally.

Macitentan 75 mg

Intervention Type DRUG

Participants will receive macitentan 75 mg film-coated tablets orally.

Placebo

Intervention Type DRUG

Participants will receive matching placebo film-coated tablets orally.

Macitentan 75 mg + Placebo

Run-in period:Participants who are either ERA-naive or who are receiving a daily dose of macitentan or ambrisentan \<10 mg, or a daily dose of bosentan \<250 mg, will enter 4-week open-label run-in period with macitentan 10 mg prior to randomization. ERA-pre-treated patients will bypass the run-in period and will be randomized to either macitentan 75 mg or macitentan 10 mg directly.DBT Period: participants will receive macitentan 37.5 mg orally for 4 weeks and macitentan 75 mg thereafter up to End of DBT. To maintain the blind, participants will receive macitentan 10 mg-matching placebo up to End of DBT.Treatment Extension Period: After EDBT, participants will continue to receive macitentan 75 mg orally for 2 years. To maintain the blind, participants will receive macitentan 37.5 mg-matching placebo during the 4-week up-titration period.

Group Type EXPERIMENTAL

Macitentan 10 mg

Intervention Type DRUG

Participants will receive macitentan 10 mg film-coated tablets orally.

Macitentan 37.5 mg

Intervention Type DRUG

Participants will receive macitentan 37.5 mg film-coated tablets orally.

Macitentan 75 mg

Intervention Type DRUG

Participants will receive macitentan 75 mg film-coated tablets orally.

Placebo

Intervention Type DRUG

Participants will receive matching placebo film-coated tablets orally.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Macitentan 10 mg

Participants will receive macitentan 10 mg film-coated tablets orally.

Intervention Type DRUG

Macitentan 37.5 mg

Participants will receive macitentan 37.5 mg film-coated tablets orally.

Intervention Type DRUG

Macitentan 75 mg

Participants will receive macitentan 75 mg film-coated tablets orally.

Intervention Type DRUG

Placebo

Participants will receive matching placebo film-coated tablets orally.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

JNJ-67896062 JNJ-67896062 JNJ-67896062

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Target population: greater than or equal to (\>=) 18 (or the legal age of consent in the jurisdiction in which the study is taking place) years of age
* Target population: Symptomatic Pulmonary Arterial Hypertension (PAH) in World Health Organization Functional Class (WHO FC) II, III, or IV
* Target population: PAH subtype falling in one of the below classifications: Idiopathic; Heritable; Drug- or toxin-induced; Related to: Connective tissue disease, HIV infection, Portal hypertension, and Congenital heart disease with small/coincidental cardiac defect with systemic-to-pulmonary shunt (for example atrial septal defect, ventricular septal defect, patent ductus arteriosus, atrioventricular septal defect) which does not account for the elevated pulmonary vascular resistance (PVR) or persistent PAH documented by an Right heart catheterization (RHC) \>= 1 year after simple systemic-to pulmonary shunt repair
* PAH diagnosis confirmed by hemodynamic evaluation at rest at any time prior to screening: Mean pulmonary artery pressure (mPAP) greater than (\>) 20 millimeters of mercury (mm Hg), and; Pulmonary artery wedge pressure (PAWP) or left ventricular end diastolic pressure (LVEDP) less than or equal to (\<=) 15 mm Hg, and PVR \>= 3 Wood Units (that is, \>= 240 dyn\*sec/cm\^5)
* Able to perform the 6-minute walking test (6MWT) with a minimum distance of 50 meters (m) and maximum distance of 440m at screening. Participants able to walk more than 440m at screening are eligible if they are in WHO FC III or IV and n-terminal prohormone of brain natriuretic peptide or n-terminal pro B-type natriuretic peptide (NT-proBNP) level is \>=300 nanograms per liter (ng/L) at screening, based on central laboratory results

Exclusion Criteria

* Known presence of three or more of the following risk factors for heart failure with preserved ejection fraction at screening, based on records that confirm documented medical history: Body mass index (BMI) \> 30 kilograms per meter square (kg/m\^2), Diabetes mellitus of any type, Essential hypertension (even if well controlled); Coronary artery disease, that is, any of the following: history of stable angina, or known more than 50 percent (%) stenosis in a coronary artery, or history of myocardial infarction, or history of or planned coronary artery bypass grafting and/or coronary artery stenting
* Presence of moderate or severe obstructive lung disease (forced expiratory volume in 1 second \[FEV1\] / forced vital capacity \[FVC\] \< 70%; and FEV1 \< 60% of predicted after bronchodilator administration) ) in participants with a known or suspected history of significant lung disease as documented by a spirometry test performed within 1 year prior to screening
* Known moderate to severe hepatic impairment, defined as Child-Pugh Class B or C, based on records that confirm documented medical history
* Serum aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) \> 1.5\*upper limit of normal (ULN) at screening
* Hemoglobin \< 100 gram per liter (g/L) (\< 10 gram per deciliter \[g/dL\]) at screening
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Actelion

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Actelion Clinical Trials

Role: STUDY_DIRECTOR

Actelion

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic

Phoenix, Arizona, United States

Site Status

Arizona Pulmonary Specialists, Ltd

Scottsdale, Arizona, United States

Site Status

Scripps Memorial Hospital

La Jolla, California, United States

Site Status

USC Keck

Los Angeles, California, United States

Site Status

Jeffrey S. Sager, MD Medical Corporation

Santa Barbara, California, United States

Site Status

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Torrance, California, United States

Site Status

National Jewish Health

Denver, Colorado, United States

Site Status

Cleveland Clinic

Weston, Florida, United States

Site Status

Piedmont Healthcare

Atlanta, Georgia, United States

Site Status

Northside Hospital

Atlanta, Georgia, United States

Site Status

Advocate Christ Medical Center

Oak Lawn, Illinois, United States

Site Status

Indiana University

Indianapolis, Indiana, United States

Site Status

St. Vincent Medical Group, Inc.

Indianapolis, Indiana, United States

Site Status

University Of Iowa - Hospitals & Clinics

Iowa City, Iowa, United States

Site Status

Norton Pulmonary Specialists

Louisville, Kentucky, United States

Site Status

Louisiana State University

New Orleans, Louisiana, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Troy Beaumont

Troy, Michigan, United States

Site Status

Washington University School Of Medicine

St Louis, Missouri, United States

Site Status

Saint Louis University Academic Pavillion

St Louis, Missouri, United States

Site Status

University of Nebraska Medical Center

Omaha, Nebraska, United States

Site Status

Reno Heart Institute

Reno, Nevada, United States

Site Status

Winthrop University Hospital

Mineola, New York, United States

Site Status

Mount Sinai

New York, New York, United States

Site Status

Columbia University

New York, New York, United States

Site Status

Stony Brook University Medical Center

Stony Brook, New York, United States

Site Status

Duke

Durham, North Carolina, United States

Site Status

Lindner Clinical Trial Center/Christ Hospital

Cincinnati, Ohio, United States

Site Status

Integris Baptist Office

Oklahoma City, Oklahoma, United States

Site Status

The Oregon Clinic

Portland, Oregon, United States

Site Status

Oregon Pulmonary Clinic

Portland, Oregon, United States

Site Status

Oregon Health And Science University

Portland, Oregon, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Allegheny General Hospital of Research

Pittsburgh, Pennsylvania, United States

Site Status

Lankenau Medical Center

Wynnewood, Pennsylvania, United States

Site Status

AnMed Health

Anderson, South Carolina, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

Baylor College of Medicine (BCM) - Baylor Heart Clinic

Houston, Texas, United States

Site Status

Baylor Scott White - Plano

Plano, Texas, United States

Site Status

San Antonio Methodist TX Transplant Physicians Group

San Antonio, Texas, United States

Site Status

The Robert Larner, M.D. College of Medicine at The University of Vermont

Burlington, Vermont, United States

Site Status

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, United States

Site Status

Medical College Of Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Sanatorio de la Trinidad Mitre

Buenos Aires, , Argentina

Site Status

Sanatorio Guemes

C.a.b.a., , Argentina

Site Status

Hospital Italiano de Buenos Aires

Caba, , Argentina

Site Status

Sanatorio Ramon Cereijo

Caba, , Argentina

Site Status

Centro Médico Dra. De Salvo

Caba, , Argentina

Site Status

Instituto de Cardiologia de Corrientes

Corrientes, , Argentina

Site Status

Instituto Medico de La Fundacion Estudios Clinicos

Rosario, , Argentina

Site Status

Instituto Cardiovascular de Rosario

Rosario, , Argentina

Site Status

Flinders Medical Centre

Bedford Park, , Australia

Site Status

Royal Prince Alfred Hospital

Camperdown, , Australia

Site Status

The Prince Charles Hospital

Chermside, , Australia

Site Status

St Vincent's hospital

Darlinghurst, , Australia

Site Status

Royal Hobart Hospital

Hobart, , Australia

Site Status

Fiona Stanley Hospital

Murdoch, , Australia

Site Status

Westmead Hospital

Westmead, , Australia

Site Status

LKH-Univ. Klinikum Graz

Graz, , Austria

Site Status

Ordensklinikum Linz GmbH Elisabethinen

Linz, , Austria

Site Status

Medical University Vienna

Vienna, , Austria

Site Status

The Republican Scientific-Practical Center ''Cardiology''

Minsk, , Belarus

Site Status

Minsk Regional Clinical Hospital

Minsk, , Belarus

Site Status

ULB Hôpital Erasme

Brussels, , Belgium

Site Status

UZ Leuven

Leuven, , Belgium

Site Status

Universidade Federal De Minas Gerais - Hospital das Clínicas

Belo Horizonte, , Brazil

Site Status

Instituto das Pequenas Missionárias de Maria Imaculada - Hospital Madre Teresa

Belo Horizonte, , Brazil

Site Status

Empresa Brasileira de Servicos Hospitalares-EBSERH-Hospital Universitario de Brasilia

Brasília, , Brazil

Site Status

Sociedade Hospitalar Angelina Caron - Hospital Angelina Caron

Campina Grande do Sul, , Brazil

Site Status

Ceti - Centro de Estudos Em Terapias Inovadoras

Curitiba, , Brazil

Site Status

Ynova Pesquisa Clinica

Florianópolis, , Brazil

Site Status

Universidade Federal de Goias - Hospital das Clinicas da UFG

Goiânia, , Brazil

Site Status

Hospital das Clinicas de Porto Alegre

Porto Alegre, , Brazil

Site Status

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS

Porto Alegre, , Brazil

Site Status

Instituto de Medicina Integral Professor Fernando Figueira

Recife, , Brazil

Site Status

Fundacao do ABC Centro Universitario FMABC

Santo André, , Brazil

Site Status

Secretaria de Estado da Saude Instituto Dante Pazzanese de Cardiologia

São Paulo, , Brazil

Site Status

Hospital Das Clinicas Da Faculdade De Medicina Da USP

São Paulo, , Brazil

Site Status

Multiprofile Hospital For Active Treatment National Cardiology Hospital, Ead

Sofia, , Bulgaria

Site Status

University Multiprofile Hospital for Active Treatment- UMHAT Sveta Anna AD

Sofia, , Bulgaria

Site Status

St. Joseph's Health Centre

Hamilton, Ontario, Canada

Site Status

University of Ottawa Heart Institute

Ottawa, Ontario, Canada

Site Status

University Health Network - Toronto General Hospital

Toronto, Ontario, Canada

Site Status

Jewish General Hospital

Montreal, Quebec, Canada

Site Status

Beijing Chaoyang Hospital

Beijing, , China

Site Status

Beijing Anzhen Hospital

Beijing, , China

Site Status

Peking Union Medical College Hospital

Beijing, , China

Site Status

The Second Xiangya Hospital of Central South Hospital

Changsha, , China

Site Status

West China Hospital Sichuan University

Chengdu, , China

Site Status

The First Affiliated Hospital of Chongqing Medical University

Chongqing, , China

Site Status

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, , China

Site Status

Shanghai Pulmonary Hospital

Shanghai, , China

Site Status

Renji Hospital

Shanghai, , China

Site Status

Zhongshan Hospital Fudan University

Shanghai, , China

Site Status

The General Hospital of Northern Theater Command

Shenyang, , China

Site Status

Shengjing Hospital Of China Medical University

Shenyang, , China

Site Status

Tianjin Medical University General Hospital

Tianjin, , China

Site Status

The First Affiliated Hospital of Xian Jiaotong University

Xi'an, , China

Site Status

Fundacion Neumologica Colombiana

Bogotá, , Colombia

Site Status

Fundacion Cardiovascular de Colombia

Bucaramanga - Piedecuesta - Valle de Menzuli, , Colombia

Site Status

Clínica Imbanaco S.A.S.

Cali, , Colombia

Site Status

Centro Cardiovascular Colombiano Clínica Santa María

Medellín, , Colombia

Site Status

Hospital Universidad del Norte

Soledad, , Colombia

Site Status

General University Hospital II.department of Internal Medicine-cardiology and angiology

Prague, , Czechia

Site Status

Århus Universitetshospital, Skejby, Hjertemedicinsk Afdeling B

Aarhus, , Denmark

Site Status

CHU de Brest - Hopital de la Cavale Blanche

Brest, , France

Site Status

Hôpital Côte de Nacre

Caen, , France

Site Status

Hopital Bicetre Aphp Hopitaux Universitaires Paris Sud

Le Kremlin-Bicêtre, , France

Site Status

CHRU de Lille Hopital Claude Huriez

Lille, , France

Site Status

Aphm - Hopital Nord

Marseille, , France

Site Status

Centre Hospitalier Universitaire - de Nice - Hopital Pasteur

Nice, , France

Site Status

CHU Saint Etienne Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

Hopital Larrey CHU de Toulouse

Toulouse, , France

Site Status

Ruhr Universitat Bochum Diabeteszentrum

Bad Oeynhausen, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Medizinische Klinik und Poliklinik V Klinikum Grosshadern der LMU

München, , Germany

Site Status

Universitaetsklinikum Regensburg

Regensburg, , Germany

Site Status

University Hospital of Alexandroupolis

Alexandroupoli, , Greece

Site Status

Alexandra General Hospital of Athens

Athens, , Greece

Site Status

University Hospital Of Larissa

Larissa, , Greece

Site Status

Ahepa University General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Semmelweis Egyetem,Pulmonológiai Klinika

Budapest, , Hungary

Site Status

Gottsegen Gyorgy Orszagos Kardiovaszkularis Intezet Felnott kardiologiai osztaly

Budapest, , Hungary

Site Status

Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar

Pécs, , Hungary

Site Status

Szegedi Tudományegyetem, Általános Orvostudományi Kar, Családorvosi Intézet és rendelő

Szeged, , Hungary

Site Status

NHL Medical College (SVP Hospital IMSR)

Ahmedabad, , India

Site Status

Cims Hospital

Ahmedabad, , India

Site Status

Narayana Hrudayalaya Limited

Bangalore, , India

Site Status

SRM Medical College Hospital & Research Centre

Chengalpetu, , India

Site Status

Govindaswamy Kuppuswamy Naidu Memorial Hospital

Coimbatore, , India

Site Status

HealthWorld Hospitals

Durgapur, , India

Site Status

Renova Century Hospitals

Hyderabad, , India

Site Status

Care Hospitals

Hyderbad, , India

Site Status

Rabindranath Tagore International Institute of Cardiac Sciences

Kolkata, , India

Site Status

GB Pant Institute of Post Graduate Medical Education & Research

New Delhi, , India

Site Status

Sir Ganga Ram Hospital

New Delhi, , India

Site Status

Jawaharlal Institute of Postgraduate Medical Education and Research

Puducherry, , India

Site Status

B.D. Mehta Mahavir Heart Institute

Surat, , India

Site Status

Carmel Medical Center

Haifa, , Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Kaplan Medical Center

Rehovot, , Israel

Site Status

The Chaim Sheba Medical Center

Tel Litwinsky, , Israel

Site Status

Yitzhak Shamir Medical Center

Ẕerifin, , Israel

Site Status

ASST Grande Ospedale Metropolitano Niguarda

Milan, , Italy

Site Status

AOU Di Modena Policlinico Di Modena

Modena, , Italy

Site Status

Ospedale San Francesco

Nuoro, , Italy

Site Status

Fondazione IRCCS Policlinico San Matteo

Pavia, , Italy

Site Status

Fondazione Toscana Gabriele Monasterio CNR

Pisa, , Italy

Site Status

Policlinico Gemelli Universita Cattolica

Roma, , Italy

Site Status

The University of Tokyo Hospital

Bunkyō City, , Japan

Site Status

Kyushu University Hospital

Fukuoka, , Japan

Site Status

Kure Kyosai Hospital

Hiroshima, , Japan

Site Status

Kagoshima University Hospital

Kagoshima, , Japan

Site Status

St Marianna University Hospital

Kanagawa, , Japan

Site Status

Kanazawa University Hospital

Kanazawa, , Japan

Site Status

Kobe University Hospital

Kobe, , Japan

Site Status

Kurume University Hospital

Kurume, , Japan

Site Status

University Hospital Kyoto Prefectural University of Medicine

Kyoto, , Japan

Site Status

Kyoto University Hospital

Kyoto, , Japan

Site Status

Shinshu University Hospital

Matsumoto, , Japan

Site Status

Nagasaki University Hospital

Nagasaki, , Japan

Site Status

Nagoya University Hospital

Nagoya, , Japan

Site Status

Nagoya City University Hospital

Nagoya, , Japan

Site Status

Niigata University Medical And Dental Hospital

Niigata, , Japan

Site Status

Okayama University Hospital

Okayama, , Japan

Site Status

National Hospital Organization Okayama Medical Center

Okayama, , Japan

Site Status

Sapporo Medical University Hospital

Sapporo, , Japan

Site Status

Hokkaido University Hospital

Sapporo, , Japan

Site Status

National Cerebral and Cardiovascular Center

Suita-Shi, , Japan

Site Status

Juntendo University Hospital

Tokyo, , Japan

Site Status

Fujita Health University Hospital

Toyoake, , Japan

Site Status

University of Tsukuba Hospital

Tsukuba, , Japan

Site Status

Hospital Pulau Pinang

George Town, , Malaysia

Site Status

Hospital Serdang

Kajang, , Malaysia

Site Status

Sarawak Heart Center

Kota Samarahan, , Malaysia

Site Status

Institut Jantung Negara (National Heart Institute)

Kuala Lumpur, , Malaysia

Site Status

Consultorio Privado del Dr. Gabriel Arturo Ramos Lopez

Guadalajara, , Mexico

Site Status

Instituto Nacional de Cardiologia Dr. Ignacio Chavez

Mexico City, , Mexico

Site Status

Operadora de Hospitales Angeles SA de CV Hospital Angeles Lomas

México, , Mexico

Site Status

Hospital Universitario Dr Jose Eleuterio Gonzalez

Monterrey, , Mexico

Site Status

Unidad de Investigacion Clinica en Medicina S.C. (UDICEM)

Monterrey, , Mexico

Site Status

Centro de Investigacion Clinica Chapultepec

Morelia, , Mexico

Site Status

VUMC Amsterdam

Amsterdam, , Netherlands

Site Status

St. Antonius Ziekenhuis Nieuwegein

Nieuwegein, , Netherlands

Site Status

Radboud Umcn

Nijmegen, , Netherlands

Site Status

Erasmus MC

Rotterdam, , Netherlands

Site Status

Akershus Universitetssykehus

Nordbyhagen, , Norway

Site Status

Oslo University Hospital

Oslo, , Norway

Site Status

Uniwersytecki Szpital Kliniczny w Bialymstoku

Bialystok, , Poland

Site Status

Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Klinika Kardiologii

Bydgoszcz, , Poland

Site Status

Uniwersyteckie Centrum Kliniczne

Gdansk, , Poland

Site Status

SPSK nr 7 SUM w Katowicach Gornoslaskie Centrum Medyczne im Prof Leszka Gieca

Katowice, , Poland

Site Status

Krakowski Szpital Specjalityczny im Jana Pawla II Oddzial Kliniczny Chorob Serca i Naczyn

Krakow, , Poland

Site Status

Uniwersytecki Szpital Kliniczny nr 2 PUM w Szczecinie

Szczecin, , Poland

Site Status

Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji

Warsaw, , Poland

Site Status

Wojewodzki Szpital Specjalistyczny we Wroclawiu Osrodek Badawczo Rozwojowy

Wroclaw, , Poland

Site Status

Uls Coimbra - Hosp. Univ. Coimbra

Coimbra, , Portugal

Site Status

Uls Sao Jose - Hosp. Santa Marta

Lisbon, , Portugal

Site Status

Uls Santa Maria - Hosp. Pulido Valente

Lisbon, , Portugal

Site Status

Altay Regional Cardiological Dispensary

Barnaul, , Russia

Site Status

Chelyabinsk Regional Clinical Hospital

Chelyabinsk, , Russia

Site Status

State Autonomous HealthCare Institution 'Interregional Clinical Diagnostic Center'

Kazan', , Russia

Site Status

Scientific and Research Institution of Cardiovascular Diseases Complex Problems

Kemerovo, , Russia

Site Status

Moscow City Clinical Hospital No.51

Moscow, , Russia

Site Status

National Medical Research Center of Cardiology of MoH of Russian Federation

Moscow, , Russia

Site Status

National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation

Saint Petersburg, , Russia

Site Status

Samara Regional Clinical Cardiological Dispensary

Samara, , Russia

Site Status

State Autonomous Healthcare Institution of Tyumen Region 'Scientific and Practical Medical Center'

Tyumen, , Russia

Site Status

Volgograd Regional Clinical Cardiology Center

Volgograd, , Russia

Site Status

King Faisal Specialist Hospital & Research Center

Riyadh, , Saudi Arabia

Site Status

King Fahad Medical City

Riyadh, , Saudi Arabia

Site Status

University Clinical Center of Serbia

Belgrade, , Serbia

Site Status

Institute for Pulmonary Disease of Vojvodina

Kamenitz, , Serbia

Site Status

National University Heart Centre, Singapore

Singapore, , Singapore

Site Status

National Heart Centre (NHC) Singapore

Singapore, , Singapore

Site Status

Narodny ustav srdcovych a cievnych chorob

Bratislava, , Slovakia

Site Status

The Eastern Slovakia Institute of Cardiovascular Diseases

Košice, , Slovakia

Site Status

Milpark Hospital

Johannesburg, , South Africa

Site Status

Dr Kalla

Lenasia, , South Africa

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Hosp Univ Vall D Hebron

Barcelona, , Spain

Site Status

Hosp. Del Mar

Barcelona, , Spain

Site Status

Hosp. Univ. 12 de Octubre

Madrid, , Spain

Site Status

Hosp. Univ. La Paz

Madrid, , Spain

Site Status

Hosp. Univ. Pta. de Hierro Majadahonda

Madrid, , Spain

Site Status

Hosp. Costa Del Sol

Málaga, , Spain

Site Status

Hosp Clinico Univ de Salamanca

Salamanca, , Spain

Site Status

Sahlgrenska Universitetsjukhuset

Gothenburg, , Sweden

Site Status

Skanes universitetssjukhus

Lund, , Sweden

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Mackay Memorial Hospital

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Phramongkutklao Hospital and Medical College

Bangkok, , Thailand

Site Status

Ramathibodi Hospital Mahidol University

Bangkok, , Thailand

Site Status

Siriraj Hospital Mahidol University

Bangkok, , Thailand

Site Status

Maharaj Nakorn Chiang Mai hospital Faculty of Medicine

Chiang Mai, , Thailand

Site Status

Srinagarind Hospital, Khon Kaen University

Khon Kaen, , Thailand

Site Status

Songklanagarind hospital

Songkhla, , Thailand

Site Status

Adana City Hospital

Adana, , Turkey (Türkiye)

Site Status

Cukurova University Medical Faculty

Adana, , Turkey (Türkiye)

Site Status

Ankara Etlik Speciality Hospital

Ankara, , Turkey (Türkiye)

Site Status

Hacettepe University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Gazi University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Ankara Bilkent Sehir Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Akdeniz University Medical Faculty

Antalya, , Turkey (Türkiye)

Site Status

Bursa Yuksek Ihtisas Training and Research Hospital

Bursa, , Turkey (Türkiye)

Site Status

Pamukkale University Medical Faculty

Denizli, , Turkey (Türkiye)

Site Status

Siyami Ersek Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Marmara University Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Tepecik Training and Research Hospital

Izmir, , Turkey (Türkiye)

Site Status

Dokuz Eylul University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Kartal Kosuyolu Yuksek Ihtisas Egitim Ve Arastirma Hastanesi

Kartal Istanbul, , Turkey (Türkiye)

Site Status

Mersin University Medical Faculty

Mersin, , Turkey (Türkiye)

Site Status

CNE 'Cherkasy Regional Cardiological Center of Cherkasy Regional Council'

Cherkassy, , Ukraine

Site Status

Communal Noncommercial Enterprise Cherkasy Regional Hospital of Cherkasy Regional Council

Cherkasy, , Ukraine

Site Status

MI 'Dnipropetrovsk Regional Clinical Center of Cardiology and Cardiac Surgery'

Dnipro, , Ukraine

Site Status

CNE' City Clinical Hospital #8' of Kharkiv City Council

Kharkiv, , Ukraine

Site Status

SI National Scientific Center Institute of Cardiology of M.D. Strazhesko of NAMS of Ukraine

Kyiv, , Ukraine

Site Status

State Institute Of Phthisiology And Pulmonology N.A. F.G. Yanovskiy Of Ams Ukraine

Kyiv, , Ukraine

Site Status

Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital'

Lviv, , Ukraine

Site Status

Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council

Ternopil, , Ukraine

Site Status

Royal Free Hospital

London, , United Kingdom

Site Status

Freeman Hospital

Newcastle upon Tyne, , United Kingdom

Site Status

Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital

Sheffield, , United Kingdom

Site Status

Hanoi Medical University Hospital

Hanoi, , Vietnam

Site Status

Cho Ray Hospital

Ho Chi Minh City, , Vietnam

Site Status

Tam Anh Hospital

Ho Chi Minh City, , Vietnam

Site Status

Tam Duc Heart Hospital

Ho Chi Minh City, , Vietnam

Site Status

University Medical Center Ho Chi Minh city

Ho Chi Minh City, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Romania United States Argentina Australia Austria Belarus Belgium Brazil Bulgaria Canada China Colombia Czechia Denmark France Germany Greece Hungary India Israel Italy Japan Malaysia Mexico Netherlands Norway Poland Portugal Russia Saudi Arabia Serbia Singapore Slovakia South Africa South Korea Spain Sweden Taiwan Thailand Turkey (Türkiye) Ukraine United Kingdom Vietnam

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AC-055-315

Identifier Type: OTHER

Identifier Source: secondary_id

2019-002533-11

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

2024-515669-32-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

CR108740

Identifier Type: -

Identifier Source: org_study_id